Correlation Between Zura Bio and Apollomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zura Bio and Apollomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Apollomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and Apollomics Class A, you can compare the effects of market volatilities on Zura Bio and Apollomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Apollomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Apollomics.

Diversification Opportunities for Zura Bio and Apollomics

ZuraApollomicsDiversified AwayZuraApollomicsDiversified Away100%
0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Zura and Apollomics is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Apollomics Class A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apollomics Class A and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Apollomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apollomics Class A has no effect on the direction of Zura Bio i.e., Zura Bio and Apollomics go up and down completely randomly.

Pair Corralation between Zura Bio and Apollomics

Given the investment horizon of 90 days Zura Bio Limited is expected to under-perform the Apollomics. But the stock apears to be less risky and, when comparing its historical volatility, Zura Bio Limited is 1.05 times less risky than Apollomics. The stock trades about -0.25 of its potential returns per unit of risk. The Apollomics Class A is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest  1,054  in Apollomics Class A on December 11, 2024 and sell it today you would lose (299.00) from holding Apollomics Class A or give up 28.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Zura Bio Limited  vs.  Apollomics Class A

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -40-20020
JavaScript chart by amCharts 3.21.15ZURA APLM
       Timeline  
Zura Bio Limited 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar1.522.53
Apollomics Class A 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Apollomics Class A are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Apollomics displayed solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar789101112

Zura Bio and Apollomics Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-10.11-7.57-5.04-2.50.02.024.116.28.2910.38 0.00900.00950.01000.01050.01100.0115
JavaScript chart by amCharts 3.21.15ZURA APLM
       Returns  

Pair Trading with Zura Bio and Apollomics

The main advantage of trading using opposite Zura Bio and Apollomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Apollomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apollomics will offset losses from the drop in Apollomics' long position.
The idea behind Zura Bio Limited and Apollomics Class A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets